Stage III Breast Cancer Not Yet Recruiting Phase 2 / 3 Trials for Epirubicin (DB00445)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Not Yet Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs